Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.
暂无分享，去创建一个
Bingshu E. Chen | R. Gascoyne | L. Sehn | M. Crump | L. Shepherd | J. Sussman | B. Lemieux | S. Couban | M. Rubinger | S. Basi | D. Macdonald | G. Cantin | S. Rubin | Kevin Imrie | M. Djurfeldt